Cost-effectiveness of Shared Telemedicine Appointments in Young Adults With T1D: CoYoT1 Trial.
Source: Wan, W., et al. 2019 - Pubmed ID: 31189564
Setting: USA, Diabetes center
CT-pro
Follow up: 9 months
Sample size:
Total: 81 (70)
IG: 42 (42)
CG: 39 (28)
Inclusion criteria:
- Diabetes type 1
- Age 18-25 years
Video consultation (Web conferencing software)
Home monitoring
- Insulin pump
- Blood glucose monitor
- Continuous glucose monitor
Intervention: Patients completed 3 telemedicine visits and one in-person appointment with care provider. Before appointment pt. upload data from diabetes management devices. During telehealth visit care provider reviewed clinical data and discussed barriers to individual diabetes management. As a part of teleconsultations online group sessions were held consisting of four patients.
Duration: 12 months one appointment every 3 months.
Add on: –
Control group: Treatment as usual, in person individual appointment every 3months
Clinical effect:
- Health related utility ↓
- QALY →
- Diabetes related distress ↓
- HbA1c →
- BMI →
Patient safety: No difference in number of severe hyperglycemia (and hypoglycemia) events,
Patient experiences: IG had more study related visits but fewer non study office visits.
Staff experiences: NA
Investment:
Equipment/Materials
- Blood glucose monitor
- Continuous glucose monitor
- Web conferencing software
Running:
Staff resources
- Online individual and group sessions
Organization: NA
Health care utilization:
- Health related utility ↓
- Cost, direct →
- Cost indirect →
- Hospitalizations →